Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) FCF Margin (2023 - 2025)

Historic FCF Margin for Mereo BioPharma (MREO) over the last 2 years, with Q2 2025 value amounting to 1530.2%.

  • Mereo BioPharma's FCF Margin changed N/A to 1530.2% in Q2 2025 from the same period last year, while for Sep 2025 it was 10227.81%, marking a year-over-year decrease of 72075100.0%. This contributed to the annual value of 211.32% for FY2023, which is N/A changed from last year.
  • Per Mereo BioPharma's latest filing, its FCF Margin stood at 1530.2% for Q2 2025.
  • Over the past 5 years, Mereo BioPharma's FCF Margin peaked at 4638.33% during Q1 2025, and registered a low of 1530.2% during Q2 2025.